Anemia
📧 Sign up to get email alerts when something new happens for Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) [Phase 3]
The SWEEP Phase 3 trial evaluating HX575 for anemia associated with chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-11Clinical Trial Update: Effect of Vitamin D Supplementation on Erythropoietin Dosage in Hemodialysis Patients Who Have Vitamin D Deficiency
A trial evaluating the effect of Vitamin D supplementation on erythropoietin dosage in hemodialysis patients with Vitamin D deficiency has b…
-
CLINICAL_TRIALS withdrawal · 2014-12-09Clinical Trial Update: Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease [NA]
The clinical trial evaluating iron prophylaxis to prevent anemia in infants with cyanotic congenital heart disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-11-25Clinical Trial Update: A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate [NA]
A clinical trial evaluating analytes in blood collected with an investigational collection device versus a commercial predicate has been wit…
-
CLINICAL_TRIALS withdrawal · 2014-11-25Clinical Trial Update: A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate [NA]
A clinical trial evaluating analyte levels using an investigational blood collection device versus a commercial predicate has been withdrawn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-03-05Clinical Trial Update: Regular Consumption of Leafy Vegetable Sauces and Micro-nutrient Status of Young Children in Burkina Faso [NA]
The clinical trial examining regular consumption of leafy vegetable sauces and micronutrient status in young children in Burkina Faso was wi…
-
CLINICAL_TRIALS withdrawal · 2014-02-27Clinical Trial Update: Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation [NA]
This clinical trial update reports that the study of epoetin alfa to treat anemia after kidney transplantation has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-10-30Clinical Trial Update: Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial evaluating erythropoietin to treat anemia in chronic obstructive pulmonary disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-02Clinical Trial Update: A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
This clinical trial update reports the withdrawal of a study evaluating erythropoietin receptor agonists in anemia patients who developed an…
-
EMA withdrawal · 2013-06-28EMA Application withdrawn: Omontys (peginesatide) — Takeda Global Research and Development Centre (Europe)
EMA withdrew the application for Omontys (peginesatide) from Takeda, related to anemia.
-
CLINICAL_TRIALS withdrawal · 2013-02-07Clinical Trial Update: Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma [Phase 3]
Phase 3 trial evaluating ulipristal acetate for anemia associated with uterine fibroids has been withdrawn with no results reported.
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
EMA withdrawal · 2011-04-19EMA Application withdrawn: Epostim (epoetin alfa) — Reliance GeneMedix Plc
The EMA entry for Epostim (epoetin alfa) shows that the application was withdrawn by Reliance GeneMedix Plc for the anemia indication.
-
CLINICAL_TRIALS withdrawal · 2011-04-19Clinical Trial Update: Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia [Phase 2]
A Phase 2 trial evaluating subcutaneous rilonacept for non-dialysis-dependent chronic kidney disease with anemia was withdrawn.
-
EMA withdrawal · 2010-03-22EMA Application withdrawn: Ratioepo (epoetin theta) — Ratiopharm GmbH
EMA withdrew the application for Ratioepo (epoetin theta) by Ratiopharm GmbH for anemia-related indications.
-
CLINICAL_TRIALS withdrawal · 2009-05-11Clinical Trial Update: A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy [Phase 1, Phase 2]
An early-phase (Phase 1/2) trial of AMG 114 for anemia in cancer patients was terminated.
-
EMA withdrawal · 2009-04-23EMA Withdrawn: Dynepo (epoetin delta) — Shire Pharmaceutical Contracts Limited
Dynepo (epoetin delta) has been withdrawn from the market by Shire Pharmaceutical Contracts Limited.
-
EMA withdrawal · 2009-01-28EMA Withdrawn: Nespo (darbepoetin alfa) — Dompé Biotec S.p.A.
EMA has withdrawn Nespo (darbepoetin alfa) from Dompé Biotec S.p.A.'s portfolio.